SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-223331
Filing Date
2015-06-15
Accepted
2015-06-15 16:10:58
Documents
13
Period of Report
2015-06-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d942648d8k.htm 8-K 14608
2 EX99.1 d942648dex991.htm EX-99.1 18566
3 EX-99.2 d942648dex992.htm EX-99.2 53508
4 GRAPHIC g942648ex99_2s10gbgd.jpg GRAPHIC 79784
5 GRAPHIC g942648ex99_2s1gbgd.jpg GRAPHIC 79784
6 GRAPHIC g942648ex99_2s2gbgd.jpg GRAPHIC 21372
7 GRAPHIC g942648ex99_2s3gbgd.jpg GRAPHIC 21372
8 GRAPHIC g942648ex99_2s4gbgd.jpg GRAPHIC 58069
9 GRAPHIC g942648ex99_2s5gbgd.jpg GRAPHIC 57590
10 GRAPHIC g942648ex99_2s6gbgd.jpg GRAPHIC 50163
11 GRAPHIC g942648ex99_2s7gbgd.jpg GRAPHIC 47535
12 GRAPHIC g942648ex99_2s8gbgd.jpg GRAPHIC 21372
13 GRAPHIC g942648ex99_2s9gbgd.jpg GRAPHIC 21372
  Complete submission text file 0001193125-15-223331.txt   721043
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36152 | Film No.: 15931317
SIC: 2836 Biological Products, (No Diagnostic Substances)